{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:15:41Z","timestamp":1771568141541,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Polygenic risk score (PRS) has proved useful in predicting the risk of cardiovascular diseases (CVD) based on the genotypes of an individual, but most analyses have focused on disease onset in the general population. The usefulness of PRS to predict CVD risk among type 2 diabetes (T2D) patients remains unclear.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We built a meta-PRS<jats:sub>CVD<\/jats:sub> upon the candidate PRSs developed from state-of-the-art PRS methods for three CVD subtypes of significant importance: coronary artery disease (CAD), ischemic stroke (IS), and heart failure (HF). To evaluate the prediction performance of the meta-PRS<jats:sub>CVD<\/jats:sub>, we restricted our analysis to 21,092 white British T2D patients in the UK Biobank, among which 4,015 had CVD events.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Results showed that the meta-PRS<jats:sub>CVD<\/jats:sub> was significantly associated with CVD risk with a hazard ratio per standard deviation increase of 1.28 (95% CI: 1.23\u20131.33). The meta-PRS<jats:sub>CVD<\/jats:sub> alone predicted the CVD incidence with an area under the receiver operating characteristic curve (AUC) of 0.57 (95% CI: 0.54\u20130.59). When restricted to the early-onset patients (onset age \u2264 55), the AUC was further increased to 0.61 (95% CI 0.56\u20130.67).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our results highlight the potential role of genomic screening for secondary preventions of CVD among T2D patients, especially among early-onset patients.<\/jats:p>","DOI":"10.3389\/fbinf.2023.1320748","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:26:08Z","timestamp":1704342368000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Genomic risk prediction of cardiovascular diseases among type 2 diabetes patients in the UK Biobank"],"prefix":"10.3389","volume":"3","author":[{"given":"Yixuan","family":"Ye","sequence":"first","affiliation":[]},{"given":"Jiaqi","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Fuyuan","family":"Pang","sequence":"additional","affiliation":[]},{"given":"Can","family":"Cui","sequence":"additional","affiliation":[]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/circresaha.120.315928","article-title":"Polygenic scores to assess atherosclerotic cardiovascular disease risk","volume":"126","author":"Aragam","year":"2020","journal-title":"Circulation Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1161\/strokeaha.112.665760","article-title":"Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations","volume":"43","author":"Bevan","year":"2012","journal-title":"Stroke"},{"key":"B3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/circgenetics.111.962191","article-title":"Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study","volume":"5","author":"Carty","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/strokeaha.113.002707","article-title":"Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants","volume":"45","author":"Dichgans","year":"2014","journal-title":"Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2337\/dc08-0025","article-title":"Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study","volume":"31","author":"Fox","year":"2008","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41467-019-09718-5","article-title":"Polygenic prediction via Bayesian regression and continuous shrinkage priors","volume":"10","author":"Ge","year":"2019","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/metabo11010006","article-title":"The liability threshold model for predicting the risk of cardiovascular disease in patients with type 2 diabetes: a multi-cohort study of Korean adults","volume":"11","author":"Hong","year":"2020","journal-title":"Metabolites"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1005589","DOI":"10.1371\/journal.pcbi.1005589","article-title":"Leveraging functional annotations in genetic risk prediction for human complex diseases","volume":"13","author":"Hu","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","volume-title":"IDF diabetes atlas","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/cir.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41588-020-0705-3","article-title":"Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease","volume":"52","author":"Koyama","year":"2020","journal-title":"Nat. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamacardio.2018.1919","article-title":"A Swedish nationwide adoption study of the heritability of heart failure","volume":"3","author":"Lindgren","year":"2018","journal-title":"JAMA Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/circgenetics.111.960443","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk Equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ng.3913","article-title":"Association analyses based on false discovery rate implicate new loci for coronary artery disease","volume":"49","author":"Nelson","year":"2017","journal-title":"Nat. Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-017-0410-8","article-title":"Genetics and genomics of dilated cardiomyopathy and systolic heart failure","volume":"9","author":"Tayal","year":"2017","journal-title":"Genome Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1161\/circulationaha.116.023528","article-title":"The future of cardiovascular epidemiology","volume":"133","author":"Vasan","year":"2016","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1038\/s41598-017-03062-8","article-title":"Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure","volume":"7","author":"Verweij","year":"2017","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajhg.2015.09.001","article-title":"Modeling linkage disequilibrium increases accuracy of polygenic risk scores","volume":"97","author":"Vilhj\u00e1lmsson","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e181079","DOI":"10.1001\/jamanetworkopen.2018.1079","article-title":"Risk factors associated with major cardiovascular events 1 Year after acute myocardial infarction","volume":"1","author":"Wang","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e003128","DOI":"10.1161\/CIRCGEN.120.003128","article-title":"Interactions between enhanced polygenic risk scores and lifestyle for cardiovascular disease, diabetes, and lipid levels","volume":"14","author":"Ye","year":"2021","journal-title":"Circ. Genom Precis. Med."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2023.1320748\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:26:11Z","timestamp":1704342371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2023.1320748\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":35,"alternative-id":["10.3389\/fbinf.2023.1320748"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2023.1320748","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1320748"}}